Diagnostic criteria of autoimmune hepatitis

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 435-440

  Liberal, Rodrigo ^a,b   Grant, Charlotte R ^a   Longhi, Maria Serena ^a   Mieli Vergani, Giorgina ^a   Vergani, Diego ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI LIVER CYTOSOL TYPE 1 ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; GRANULOCYTE ANTIBODY; IMMUNOGLOBULIN G; LIVER ANTIGEN; LIVER ENZYME; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; CLINICAL FEATURE; CONSENSUS; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM SURVIVAL; REMISSION; REVIEW; SCORING SYSTEM;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; HEPATITIS, AUTOIMMUNE; HUMANS;

EID: 84896320067     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.11.009     Document Type: Review

References (40)

1. Waldenstrom J. Leber, Blutprotein und Nahrungseiweiss. Dtsch Ges Z Verdan Stoffwechselkr 1950, 15:113-119.
2. Mackay I.R. Toward diagnostic criteria for autoimmune hepatitis. Hepatology 1993, 18:1006-1008.
3. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 2006, 354:54-66.
4. Vergani D., Alvarez F., Bianchi F.B., Cancado E.L., Mackay I.R., Manns M.P., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004, 41:677-683.
5. Al-Chalabi T., Boccato S., Portmann B.C., McFarlane I.G., Heneghan M.A. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006, 45:575-583.
6. Czaja A.J., Carpenter H.A. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 2006, 43:532-538.
7. Liberal R., Grant C.R., Mieli-Vergani G., Vergani D. Autoimmune hepatitis: a comprehensive review. J Autoimmun 2013, 41:126-139.
8. Johnson P.J., McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993, 18:998-1005.
9. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
10. Hurlburt K.J., McMahon B.J., Deubner H., Hsu-Trawinski B., Williams J.L., Kowdley K.V. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002, 97:2402-2407.
11. Ngu J.H., Bechly K., Chapman B.A., Burt M.J., Barclay M.L., Gearry R.B., et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women?. J Gastroenterol Hepatol 2010, 25:1681-1686.
12. Krawitt E.L. Clinical features and management of autoimmune hepatitis. World J Gastroenterol 2008, 14:3301-3305.
13. Vergani D., Mieli-Vergani G. Cutting edge issues in autoimmune hepatitis. Clin Rev Allergy Immunol 2012, 42:309-321.
14. Gregorio G.V., Portmann B., Reid F., Donaldson P.T., Doherty D.G., McCartney M., et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997, 25:541-547.
15. Kessler W.R., Cummings O.W., Eckert G., Chalasani N., Lumeng L., Kwo P.Y. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004, 2:625-631.
16. Samuel D., Riordan S., Strasser S., Kurtovic J., Singh-Grewel I., Koorey D. Severe autoimmune hepatitis first presenting in the early post partum period. Clin Gastroenterol Hepatol 2004, 2:622-624.
17. Heneghan M.A., Norris S.M., O'Grady J.G., Harrison P.M., McFarlane I.G. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001, 48:97-102.
18. Yeoman A.D., Al-Chalabi T., Karani J.B., Quaglia A., Devlin J., Mieli-Vergani G., et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology 2008, 48:863-870.
19. Wong R.J., Gish R., Frederick T., Bzowej N., Frenette C. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci 2011, 56:578-585.
20. Manns M.P., Czaja A.J., Gorham J.D., Krawitt E.L., Mieli-Vergani G., Vergani D., et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010, 51:2193-2213.
21. Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.L., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
22. Bogdanos D.P., Invernizzi P., Mackay I.R., Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008, 14:3374-3387.
23. Bogdanos D.P., Mieli-Vergani G., Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 2009, 29:241-253.
24. Vogel A., Strassburg C.P., Obermayer-Straub P., Brabant G., Manns M.P. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med 2002, 80:201-211.
25. Beaune P., Dansette P.M., Mansuy D., Kiffel L., Finck M., Amar C., et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A 1987, 84:551-555.
26. Crivelli O., Lavarini C., Chiaberge E., Amoroso A., Farci P., Negro F., et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol 1983, 54:232-238.
27. Strassburg C.P., Obermayer-Straub P., Alex B., Durazzo M., Rizzetto M., Tukey R.H., et al. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. Gastroenterology 1996, 111:1576-1586.
28. Ma Y., Okamoto M., Thomas M.G., Bogdanos D.P., Lopes A.R., Portmann B., et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002, 35:658-664.
29. Wies I., Brunner S., Henninger J., Herkel J., Kanzler S., Meyer zum Buschenfelde K.H., et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 2000, 355:1510-1515.
30. Czaja A.J., Carpenter H.A. Autoimmune hepatitis. Pathology of the Liver: Churchill Livingstone 2001, 415-434. R.N.M. Macsween, A.D. Burt, B.C. Portmann (Eds.).
31. Gregorio G.V., Portmann B., Karani J., Harrison P., Donaldson P.T., Vergani D., et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001, 33:544-553.
32. Vergani D., Longhi M.S., Bogdanos D.P., Ma Y., Mieli-Vergani G. Autoimmune hepatitis. Semin Immunopathol 2009, 31:421-435.
33. Vergani D., Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother 2011, 12:607-613.
34. Liberal R., Zen Y., Mieli-Vergani G., Vergani D. Liver transplantation and autoimmune liver diseases. Liver Transpl 2013, 19:1065-1077.
35. Liberal R., Longhi M.S., Grant C.R., Mieli-Vergani G., Vergani D. Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol 2012, 10:346-353.
36. Longhi M.S., Ma Y., Grant C.R., Samyn M., Gordon P., Mieli-Vergani G., et al. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. J Autoimmun 2013, 41:146-151.
37. Muratori L., Longhi M.S. The interplay between regulatory and effector T cells in autoimmune hepatitis: implications for innovative treatment strategies. J Autoimmun 2013 Oct, 46:74-80.
38. Floreani A., Liberal R., Vergani D., Mieli-Vergani G. Autoimmune hepatitis: contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun 2013, 46:7-16.
39. Liberal R., Mieli-Vergani G., Vergani D. Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun 2013, 46:17-24.
40. Invernizzi P. Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ. J Autoimmun 2013, 46:1-6.